CDMO News
Telix Expands Manufacturing Capabilities with IsoTherapeutics (CDMO) Purchase
Telix Pharmaceuticals, an Australian company, has announced its agreement to acquire IsoTherapeutics Group, LLC, a specialty radiopharmaceutical development and bioconjugation firm based in Angleton, Texas. This strategic move is set to bolster Telix’s in-house drug development capabilities and expand its US
29 February 2024